Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    June 2018
  1. MACHADO-SANTOS J, Saji E, Troscher AR, Paunovic M, et al
    The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
    Brain. 2018 Jun 4. pii: 5032773. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. STANKOFF B, Louapre C
    Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
    Brain. 2018;141:1580-1583.
    PubMed     Text format    


    May 2018
  3. CAMARA-LEMARROY CR, Metz L, Meddings JB, Sharkey KA, et al
    The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.
    Brain. 2018 May 30. pii: 5025744. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. BARRO C, Benkert P, Disanto G, Tsagkas C, et al
    Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Brain. 2018 May 30. pii: 5025690. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. ESHAGHI A, Marinescu RV, Young AL, Firth NC, et al
    Progression of regional grey matter atrophy in multiple sclerosis.
    Brain. 2018 May 8. pii: 4993898. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  6. CONRAD BN, Barry RL, Rogers BP, Maki S, et al
    Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord.
    Brain. 2018 Apr 10. pii: 4965865. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. VAN LANGELAAR J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, et al
    T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
    Brain. 2018 Apr 5. pii: 4961484. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  8. STEYERBERG EW, Claggett B
    Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919652. doi: 10.1093.
    PubMed     Text format    


  9. KALINCIK T
    Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919653. doi: 10.1093.
    PubMed     Text format    


  10. STEPHENSON EL, Mishra MK, Moussienko D, Laflamme N, et al
    Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
    Brain. 2018 Mar 1. pii: 4915907. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  11. ARRAMBIDE G, Tintore M, Espejo C, Auger C, et al
    The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
    Brain. 2018 Feb 16. pii: 4866204. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  12. SMETS I, Fiddes B, Garcia-Perez JE, He D, et al
    Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.
    Brain. 2018 Jan 18. pii: 4817414. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  13. GRANBERG T, Fan Q, Treaba CA, Ouellette R, et al
    In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Brain. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  14. ROCCA MA, Sormani MP, Rovaris M, Caputo D, et al
    Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
    Brain. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. DATTA G, Colasanti A, Rabiner EA, Gunn RN, et al
    Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Brain. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. KALINCIK T, Manouchehrinia A, Sobisek L, Jokubaitis V, et al
    Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
    Brain. 2017;140:2426-2443.
    PubMed     Text format     Abstract available


    July 2017
  17. SCOLDING NJ, Pasquini M, Reingold SC, Cohen JA, et al
    Cell-based therapeutic strategies for multiple sclerosis.
    Brain. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  18. ZRZAVY T, Hametner S, Wimmer I, Butovsky O, et al
    Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
    Brain. 2017 May 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. HACOHEN Y, Ciccarelli O, Hemingway C
    Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.
    Brain. 2017;140:1172-1174.
    PubMed     Text format    


    April 2017
  20. EL BEHI M, Sanson C, Bachelin C, Guillot-Noel L, et al
    Adaptive human immunity drives remyelination in a mouse model of demyelination.
    Brain. 2017;140:967-980.
    PubMed     Text format     Abstract available


    March 2017
  21. LONGONI G, Brown RA, MomayyezSiahkal P, Elliott C, et al
    White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Brain. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. JURYNCZYK M, Geraldes R, Probert F, Woodhall MR, et al
    Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Brain. 2017;140:617-627.
    PubMed     Text format     Abstract available


    January 2017
  23. BROWN JW, Pardini M, Brownlee WJ, Fernando K, et al
    An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis.
    Brain. 2017 Jan 2. pii: aww296. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  24. CORREALE J, Gaitan MI, Ysrraelit MC, Fiol MP, et al
    Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
    Brain. 2016.
    PubMed     Text format     Abstract available


    August 2016
  25. KNIER B, Schmidt P, Aly L, Buck D, et al
    Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
    Brain. 2016.
    PubMed     Text format     Abstract available


    July 2016
  26. LORSCHEIDER J, Buzzard K, Jokubaitis V, Spelman T, et al
    Defining secondary progressive multiple sclerosis.
    Brain. 2016.
    PubMed     Text format     Abstract available


    April 2016
  27. SEVERIN ME, Lee PW, Liu Y, Selhorst AJ, et al
    MicroRNAs targeting TGFbeta signalling underlie the regulatory T cell defect in multiple sclerosis.
    Brain. 2016.
    PubMed     Text format     Abstract available


    March 2016
  28. KILSDONK ID, Jonkman LE, Klaver R, van Veluw SJ, et al
    Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
    Brain. 2016.
    PubMed     Text format     Abstract available


  29. HAIDER L, Zrzavy T, Hametner S, Hoftberger R, et al
    The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
    Brain. 2016;139.
    PubMed     Text format     Abstract available


    January 2016
  30. PETRACCA M, Vancea RO, Fleysher L, Jonkman LE, et al
    Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
    Brain. 2016.
    PubMed     Text format     Abstract available


  31. CHARD DT, Miller DH
    What lies beneath grey matter atrophy in multiple sclerosis?
    Brain. 2016;139.
    PubMed     Text format    


  32. FRIESE MA
    Widespread synaptic loss in multiple sclerosis.
    Brain. 2016;139.
    PubMed     Text format    


    December 2015
  33. JURGENS T, Jafari M, Kreutzfeldt M, Bahn E, et al
    Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
    Brain. 2015.
    PubMed     Text format     Abstract available


  34. STEENWIJK MD, Geurts JJ, Daams M, Tijms BM, et al
    Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Brain. 2015.
    PubMed     Text format     Abstract available


    November 2015
  35. MUSOLINO PL, Gong Y, Snyder JM, Jimenez S, et al
    Brain endothelial dysfunction in cerebral adrenoleukodystrophy.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    September 2015
  36. IAFFALDANO P, Lucisano G, Pozzilli C, Brescia Morra V, et al
    Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
    Brain. 2015.
    PubMed     Text format     Abstract available


  37. KALINCIK T, Cutter G, Spelman T, Jokubaitis V, et al
    Defining reliable disability outcomes in multiple sclerosis.
    Brain. 2015.
    PubMed     Text format     Abstract available


  38. PIEDAVENT-SALOMON M, Willing A, Engler JB, Steinbach K, et al
    Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
    Brain. 2015.
    PubMed     Text format     Abstract available


  39. CAWLEY N, Solanky BS, Muhlert N, Tur C, et al
    Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  40. DE STEFANO N, Giorgio A
    GABA: a new imaging biomarker of neurodegeneration in multiple sclerosis?
    Brain. 2015;138.
    PubMed     Text format    


  41. NAISMITH RT, Cross AH
    Enhancing our understanding of white matter changes in early multiple sclerosis.
    Brain. 2015;138.
    PubMed     Text format    


    July 2015
  42. CRAMER SP, Modvig S, Simonsen HJ, Frederiksen JL, et al
    Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
    Brain. 2015.
    PubMed     Text format     Abstract available


    June 2015
  43. PODJASKI C, Alvarez JI, Bourbonniere L, Larouche S, et al
    Netrin 1 regulates blood-brain barrier function and neuroinflammation.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  44. CHAPOULY C, Tadesse Argaw A, Horng S, Castro K, et al
    Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: